Shanghai AQ BioPharma Co., Ltd. attends 2021 CPHI North America online

Shanghai AQ BioPharma, a leading company specialized in the fluorine-containing building blocks and highly valuable pharmaceutical intermediates or chemicals, attends 2021 CPHI North America online. We have a 30000-sqft R&D center and a full-owned 50-acre plant in Zhejiang for the production. Our featured products include: fluorinated intermediates, piperidines, pyrrolidines, azetidines, etc.

Shanghai AQ BioPharma was founded in 2007 and we have been committed to innovative fluorine-containing drug discovery and the development and manufacture of fluorinated intermediates or chemicals to addressing worldwide healthcare needs. We are a leading supplier specialized in the fluorine-containing building blocks and we also have businesses in high valuable intermediates or chemicals. We have established collaboration with more than 700 international partners, including the world’s top pharmaceutical giants, research institutions and universities, and we can provide products for our partners from milligrams, grams to kilograms and tons. With endeavors in the innovative fluorine-containing building blocks for near 15 years, we hold more than 30patents and more than 3000 novel products have been designed and developed in our catalog. We have a 30000-sqft R&D center and we also have a full-owned 50-acre plant for the manufacture of fluorinated products. Our featured products include: fluorinated drug intermediates, piperidines, piperazines, pyrrolidines, azaindoles, adamantanes, azaspiroes and azafused heterocycles etc.